Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $27.8000 (-1.59%) ($27.7800 - $28.4100) on Tue. Sep. 11, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.16% (three month average) | RSI | 66 | Latest Price | $27.8000(-1.59%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IWM(33%) QQQ(32%) SPY(32%) XLK(28%) XLY(27%) | Factors Impacting SGEN price | SGEN will decline at least -1.08% in a week (0% probabilities). TLT(-10%) SHY(-4%) IGOV(-3%) TIP(-1%) GLD(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.08% (StdDev 2.16%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
5 Day Moving Average | $28.66(-3%) | 10 Day Moving Average | $27.85(-0.18%) | 20 Day Moving Average | $27.04(2.81%) | To recent high | -6.3% | To recent low | 21.4% | Market Cap | $4.833b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |